Those protections are at the heart of the proposed deal that would end claims filed by thousands of state, local and Native American tribal governments and other entities.Sackler family members have been clearthat without the protections, they won't hold up their part of the deal. "It'...
respond to claims and legal process (e.g., subpoenas); and/or protect against legal liability. If you contact us regarding your experience with using any of our products, we may use the information you provide in submitting reports to the U.S. Food and Drug Administration, and as otherwis...
Purdue Pharma went on toannouncesuspension of the drug promotion in February last year. Filed in 2017, the Oklahoma lawsuit is the first of more than 2,000 claims filed in various states against Purdue Pharma and other opioid manufacturers. How well do youreallyknow your competitors? Access th...
Purdue Pharma is close to a new bankruptcy settlement with its owners, members of the wealthy Sackler family, and state and local governments that have filed lawsuits alleging that its painkiller OxyContin spurred a deadly opioid-addiction crisis in the U.S., … ...
There have been a series of big settlement deals for companies involved in the opioid analgesic business in the US of late, including payments of $270 million and $85 million respectively for Purdue Pharma and Teva in Oklahoma over claims they encouraged over-prescribing of medicines. Johnson &...
Purdue Pharma, which helped revolutionize the prescription painkiller business with its drug OxyContin, is proposing a $10 billion plan to emerge from bankruptcy that calls for it to be transformed in...
Purdue Pharma has pleaded guilty in federal court in Newark, New Jersey, to criminal charges over the handling of its OxyContin painkiller.
Nature of Case and Issue(s) Presented: The ’933 patent claims both a product (an oxycodone composition) and a process for preparing the product by removing a source of 14-hydroxy from that product. The ’497 and ’717 patents (“the irritant patents”) share a specification and are direc...
Publicis Groupe SA agreed Thursday to pay $350 million to settle claims it helped OxyContin maker Purdue Pharma fuel the opioids epidemic in the United States.
Stay up-to-date with breaking news and top stories on Purdue Pharma LP. In-depth analysis, industry insights and expert opinion